Experience expert-guided weight loss designed around your unique goals where every patient is a VIP Your path to better health, renewed confidence, and vibrant living starts here
Comparing Clinical Evidence: GLP-1 Receptor Agonists vs Antioxidant Therapy Randomized controlled trials of semaglutide, including SUSTAIN and STEP studies, consistently show significant weight loss, improved blood sugar control, and reduced cardiovascular risk markers
Once retatrutide is approved, expect a similar program to launch within 6 to 12 months
Novo Nordisk said it was exploring all possible legal avenues to challenge ANSMs decision
Vitamin D levels typically respond within 8-12 weeks at therapeutic doses
International organizations suggest a cut-off level between 300-350 ng/dl for testosterone deficiency